> top > docs > PubMed:25975632 > annotations

PubMed:25975632 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
25975632-0#130#134#gene2064 130-134 gene2064 denotes HER2
25975632-0#150#163#diseaseC0006142 150-163 diseaseC0006142 denotes breast cancer
25975632-0#150#163#diseaseC0678222 150-163 diseaseC0678222 denotes breast cancer
25975632-0#165#171#diseaseC0006142 165-171 diseaseC0006142 denotes ARTemi
25975632-0#165#171#diseaseC0678222 165-171 diseaseC0678222 denotes ARTemi
25975632-2#98#102#gene2064 499-503 gene2064 denotes HER2
25975632-2#118#140#diseaseC0853879 519-541 diseaseC0853879 denotes invasive breast cancer
130#134#gene2064150#163#diseaseC0006142 25975632-0#130#134#gene2064 25975632-0#150#163#diseaseC0006142 associated_with HER2,breast cancer
130#134#gene2064150#163#diseaseC0678222 25975632-0#130#134#gene2064 25975632-0#150#163#diseaseC0678222 associated_with HER2,breast cancer
130#134#gene2064165#171#diseaseC0006142 25975632-0#130#134#gene2064 25975632-0#165#171#diseaseC0006142 associated_with HER2,ARTemi
130#134#gene2064165#171#diseaseC0678222 25975632-0#130#134#gene2064 25975632-0#165#171#diseaseC0678222 associated_with HER2,ARTemi
98#102#gene2064118#140#diseaseC0853879 25975632-2#98#102#gene2064 25975632-2#118#140#diseaseC0853879 associated_with HER2,invasive breast cancer

Zierdiyeerkenaili_800_3

Id Subject Object Predicate Lexical cue
T10 97-113 CI denotes cyclophosphamide
T11 870-886 CI denotes cyclophosphamide
T12 960-971 CI denotes bevacizumab
T13 24-35 CI denotes bevacizumab
T14 305-316 CI denotes bevacizumab
T15 1556-1567 CI denotes bevacizumab
T16 2041-2052 CI denotes bevacizumab
T17 2522-2533 CI denotes bevacizumab
T18 1715-1718 CI denotes Bev
T19 984-987 CI denotes Bev
T20 1439-1442 CI denotes Bev
T21 1934-1937 CI denotes Bev
T22 921-926 CI denotes D-FEC
T23 988-993 CI denotes D-FEC
T24 1421-1426 CI denotes D-FEC
T25 1443-1448 CI denotes D-FEC
T26 1719-1724 CI denotes D-FEC
T27 1784-1789 CI denotes D-FEC
T28 1938-1943 CI denotes D-FEC
T29 1962-1967 CI denotes D-FEC
T30 2056-2061 CI denotes D-FEC
T6 812-824 CI denotes fluorouracil
T7 67-79 CI denotes fluorouracil
T8 840-850 CI denotes epirubicin
T9 81-91 CI denotes epirubicin
T31 45-54 CI denotes docetaxel
T32 741-750 CI denotes docetaxel
T34 2446-2459 DP denotes breast cancer
T35 150-163 DP denotes breast cancer
T36 377-390 DP denotes breast cancer
T37 528-541 DP denotes breast cancer
T38 2085-2098 DP denotes breast cancer

yaoziqian_800_3

Id Subject Object Predicate Lexical cue
T10 741-750 CI denotes docetaxel
T11 812-824 CI denotes fluorouracil
T12 840-850 CI denotes epirubicin
T13 870-886 CI denotes cyclophosphamide
T15 24-35 CI denotes bevacizumab
T16 305-316 CI denotes bevacizumab
T17 960-971 CI denotes bevacizumab
T18 1556-1567 CI denotes bevacizumab
T19 2041-2052 CI denotes bevacizumab
T2 67-79 CI denotes fluorouracil
T20 2522-2533 CI denotes bevacizumab
T3 81-91 CI denotes epirubicin
T4 97-113 CI denotes cyclophosphamide
T5 45-54 CI denotes docetaxel
T25 2446-2459 DP denotes breast cancer
T26 150-163 DP denotes breast cancer
T27 377-390 DP denotes breast cancer
T28 528-541 DP denotes breast cancer
T29 2085-2098 DP denotes breast cancer
T30 984-987 CI denotes Bev
T31 1439-1442 CI denotes Bev
T32 1715-1718 CI denotes Bev
T33 1934-1937 CI denotes Bev
T34 1719-1724 CI denotes D-FEC
T35 921-926 CI denotes D-FEC
T36 988-993 CI denotes D-FEC
T37 1421-1426 CI denotes D-FEC
T38 1443-1448 CI denotes D-FEC
T39 1784-1789 CI denotes D-FEC
T40 1938-1943 CI denotes D-FEC
T41 1962-1967 CI denotes D-FEC
T42 2056-2061 CI denotes D-FEC